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Significant statement 19
Down syndrome (DS) is the most common genetic disorder caused by trisomy of chromosome 20 21 (HSA21). Problems with cognitive impairment, have not been properly addressed due to the 21 inability to fully recapitulate HSA21, which is further confounded by the snapshot views of 22 morphological changes of brain cells in isolation obtained from current studies. The brain 23 develops neural networks consisting of neurons and glial cells that work together. To 24 understand how DS affects the neural networks, we used DS patient-derived stem cells and 25 calcium imaging to investigate functional defects of DS astrocytes and their effects on neuronal 26 excitability. Our study has significant implication in understanding functional defects during brain 27 development underlying DS. 28
Introduction 30
Down syndrome (DS) is a neurodevelopmental disorder occurring in 1 in 750 live births 31 worldwide. DS is caused by trisomy of chromosome 21 (Ts21) 1 , leading to triplication of up to 32 400 genes, resulting in an array of phenotypes, including profoundly impaired cognitive function. 33
The brains of DS patients demonstrate consistent pathophysiological changes, such as reduced 34 volume, altered neuronal densities and structure, and disturbed balance of all cell types. 35
Confronted with this genetic complexity, it is difficult to determine precise molecular and cellular 36 mechanisms of disease establishment and maintenance. Consequently, there are no 37 therapeutic approaches to mitigate the effects of DS. 38
39
To date, DS pathophysiology has been primarily studied in rodent models, (e.g. Ts65Dn, Ts1cje 40 and Ts1Rhr) 2 . Though useful information has been revealed, rodent models do not faithfully 41 reproduce DS pathophysiology, due in part to incomplete synteny between HSA21 and the 42 homologous mouse regions. Furthermore, rodent modeling of complex neurodevelopmental 43 disorders such as DS is limited by the fact that the human brain is far more complicated than the 44 rodent brain in terms of structure of the neural circuitry, plasticity, and cognitive capacity. 45 46 Advances in induced pluripotent stem cell (iPSC) technology have enabled the modeling of 47 complex diseases such as DS in the context of human cell biology 3, 4 . These models are highly 48 desirable for understanding disease neuropathophysiology and for developing therapeutics. By 49 culturing iPSCs from DS individuals it is possible to achieve full expression of the human HSA21 50 region. In addition, the use of isogenic control lines eliminates inter-individual variability, 51 restricting genotype differences solely to HSA21 dosage. 52
53
Results 90
Generation and differentiation of astroglia from human Ts21 iPSCs 91
Using established protocols 24 , we differentiated astroglia from previously reported iPSC lines by 92 Weick et al., DS1 and DS4, which are trisomic for chromosome 21, and DS2U, a control 93 isogenic line (Supplementary Fig. 1a-b) 4 . After 120 days, all three iPSC lines robustly 94 expressed astrocyte precursor marker CD44, mature astrocyte markers glia fibrillary acidic 95 protein (GFAP) and aquaporin 4 (AQP4), as determined by immunofluorescence and confirmed 96 by quantitative reverse transcription PCR (qPCR) (Supplementary Fig. 1d-f , Supplementary 97 Table 1 ). Karyotype analysis prior to and after experiments confirmed trisomy of DS1-and 98 DS4-derived astroglia (DS1A and DS4A) and disomy of DS2U-induced astroglia (DS2UA) 99
( Supplementary Fig. 1b ). Using qPCR, we further observed global expression of a panel of 100 astrocyte specific markers such as excitatory amino acid transporter 1 (EAAT1), aldolase C 101 (ALDOC), connexin-43 (CX43), SOX9, and nuclear factor I A (NFIA) in all three lines 102 ( Supplementary Fig. 1c ) 9 , indicating successful astroglia differentiation of the iPSCs. 103
Consistent with previous reports, DS astroglia showed increased expression levels of HSA21 104 genes compared to control astroglia, including S100β 25 , amyloid beta precursor protein (APP) 23 105 and transcription factor ETS2 26 , as well as higher levels of non-HSA21 genes associated with 106 oxidative stress, such as catalase (CAT) 27 and quinone oxidoreductase 107 (CRYZ) 4 ( Supplementary Fig. 1c ). Morphologically, DS astroglia occupied larger territories than 108 DS2UA; the total arborization size of DS astrocytes was significantly greater than that of control 109 isogenic astroglia (Supplementary Fig. 1g ). 110
111

DS astroglia inhibit the excitability of co-cultured neurons 112
We next studied the potential influence of DS astroglia on co-cultured neurons. Using 113 established protocols 28,29 , three lines of cortical TUJ1 + (neural-specific β-III tubulin) neurons 114 were differentiated from the DS1 and DS2U iPSC lines and a control H9 human embryonic stem 115 cell (hESC) line ( Supplementary Fig. 2a-b) . Differentiated neurons were infected with 116 lentivirus encoding GCaMP6m driven by the neuron specific promoter synapsin-1 117 ( Supplementary Fig. 2c ). To establish a baseline of neuronal excitability, we monitored 118 fluorescence changes in neurons in response to a series of electrically evoked field potentials 119 (FPs) in the absence of astrocytes. The magnitude of evoked Ca 2+ transients in neurons 120 increased with the number of applied FPs (Fig. 1a) . Evoked signals were abolished by addition 121 of 1 µM tetrodotoxin (TTX; a voltage-gated sodium channel blocker) ( Fig. 1a ), suggesting that 122 Ca 2+ signals in neurons were triggered by action potentials. The expression of multiple voltage-123 gated sodium-channel isoforms in differentiated neurons was confirmed by qPCR assay 124 ( Supplementary Fig. 2d ). 125
126
After confirming the basis of neuronal excitability, we recorded neuronal activity when co-127 cultured with DS1-, DS4-, or DS2U-derived astroglia, as well as human primary astrocytes (HA). 128 H9 hESC-derived neurons co-cultured with DS astroglia (DS1A or DS4A) showed significantly 129 decreased FP-evoked Ca 2+ amplitudes relative to neurons cultured alone (normalized ∆F/F; 130 DS1A: 0.63±0.06, P=0.0042; DS4A: 0.57±0.05, P<0.001), whereas neurons co-cultured with 131 control isogenic astrocytes (DSU2A) or human primary astrocytes were not significantly affected 132 (DS2UA: 1.00±0.04, P=0.93; HA: 0.88±0.04, P=0.059; Fig. 1b) . 
150
Similar neuronal-activity suppression imposed by DS astroglia was also observed in neurons 152 derived from the two other iPSC lines. DS2U derived neurons co-cultured with DS astroglia 153 (DS1A or DS4A) showed significantly decreased FP-evoked Ca 2+ amplitudes relative to neurons 154 cultured alone (normalized ∆F/F; DS1A: 0.57±0.04, P<0.001; DS4A: 0.51±0.04, P<0.001; 155 DS2UA: 0.99±0.03, P=0.89; HA: 0.93±0.04, P=0.18; Fig. 1c ). Likewise, DS1 derived neurons 156 co-cultured with DS astroglia (DS1A or DS4A) showed significantly decreased FP-evoked Ca 2+ 157 amplitudes relative to neurons cultured alone (normalized ∆F/F; DS1A: 0.66±0.07, P=0.0092; 158 DS4A: 0.43±0.05, P<0.001; DS2UA: 0.92±0.04, P=0.15; HA: 0.95±0.03; P=0.18; Fig. 1d ). 159
Decreased neuronal activity in the presence of DS astroglia was observed under a variety of 160 stimulation conditions, but was most prominent during modest stimulation such as 10FPs 161
( Supplementary Fig. 2e ). Taken together, DS astroglia inhibited neuronal excitability of 162 neurons derived from either trisomy or disomy iPSC lines. 163
164
In addition, all co-cultured astrocytes significantly accelerated decay-to-baseline of evoked 165 neuronal Ca 2+ transients (T 0.5 =1.62±0.14 for neuron-alone; T 0.5 =1.22±0.08, 1.25±0.12, 166 1.11±0.13, and 1.18±0.1 for neurons co-cultured with HA, DS2UA, DS1A, and DS4A 167 respectively, P<0.01; Supplementary Fig. 2f ), presumably because astrocytic glutamate 168 clearance following FP-evoked release occurs at similar rates. 169
170
DS astroglia promote synaptic connectivity 171
As DS astroglia suppress neuronal activity, we next sought to determine if DS astroglia 172 influence synaptic function. DS astroglia were co-cultured with dissociated rat hippocampal 173 neurons, and miniature excitatory post-synaptic currents (mEPSCs) were recorded in the 174 presence of TTX, NMDA receptor antagonist D-AP5, and GABA A antagonist bicuculline, to 175 isolate the fast AMPA receptor-mediated mEPSC component ( Fig. 1e-g Fisher's least-significant difference test) ( Fig. 1f, Supplementary Fig. 2g , P<0.05). mEPSC 180 frequency was similar in all three groups, with a trend towards higher mEPSC frequencies in the 181 neurons co-cultured with DS4A and DS1A groups (P=0.204; DS2UA: 0.56±0.06; DS1A: 182 1.29±0.45; DS4A: 1.10±0.36) ( Fig. 1g, Supplementary Fig. 2h ). 183
184
We next evaluated the effects of human astroglia on synapse formation using quantitative 185 image analysis 30 . We quantified the density of punctae expressing both the pre-synaptic protein 186 synapsin-I and the post-synaptic scaffolding protein PSD95 on oblique dendrites of rat 187 hippocampal neurons co-cultured with astroglia. We found that synapse density significantly 188 increased by 1.5-and 1.3-fold in neurons co-cultured with DS astrocytes (DS1A, (P=0.0039); 189 DS4A, (P=0.02), respectively) compared with those co-cultured with isogenic control astrocytes 190 ( Fig. 1h) . Taken together, these results suggest that DS astroglia are capable of modulating 191 neuronal excitability, as well as synaptic activity and density. Next we examined the chemical transmitter ATP, since astrocytic release of ATP has been 205 shown to modulate synaptic function, with intracellular Ca 2+ transients increasing probability of 206 release 16, 18, 19 . To what extent ATP potentiates and/or inhibits neuronal activity is still under 207 debate; however, adenosine, a rapid ATP breakdown product, has been shown to inhibit 208 synaptic activity via G i -coupled A 1 adenosine receptors [32] [33] [34] [35] [36] . To test whether suppressed 209 neuronal excitability is caused by adenosine-mediated signaling, we treated H9 neurons co-210 cultured with DS astroglia (DS4A) with an adenosine receptor antagonist, followed by imaging 211 FP-evoked neuronal activity. In particular, the A 1 receptor antagonist DPCPX fully rescued 212 suppressed neuronal activity, especially at lower concentrations (100 nM: normalized 213 ∆F/F=1.20±0.09, P=0.004; 1 µM: 0.98±0.08, P=0.018; n=3; Fig. 1i ). This suggests that the 214 suppressed neuronal excitability is influenced by purinergic signaling. 215
216
DS astroglia exhibit abnormally frequent spontaneous Ca 2+ fluctuations 217
Astrocytic Ca 2+ signaling has been proposed to modulate neural-circuit activity and structure 37,38 ; 218 the suppressed excitability of neurons was specific to DS astroglia and could be rescued when 219 astrocyte-neuron communication was blocked by an adenosine receptor antagonist. This 220 evidence led us to further investigate calcium dynamics in astroglia. We focused on optical 221 recordings of calcium dynamics in astroglia using the genetically encoded indicator GCaMP6m 39 . 222
We used the machine-learning software Functional Astrocyte Phenotyping (FASP) 40 to facilitate 223 automated detection and analysis of complex Ca 2+ dynamics in astroglia. 224
225
The differentiated astroglia indeed displayed prominent spontaneous Ca 2+ transients, which 226
were frequently periodic and especially apparent in DS astroglia ( Fig. 2a, Supplementary  227 Movie 1&2). DS astroglia exhibited significantly more (7-34-fold) Ca 2+ transients than control isogenic astroglia (averaged number of calcium transients in a 5-min imaging session: DS1A: 229 58±6, DS4A: 275±34, DS2UA: 8±2, mean±s.e.m.; P<0.0001, unpaired t-test, n=9 imaging 230 sessions) (Fig. 2b) . The average amplitude (ΔF/F; DS1A: 1.45±0.2, DS4A: 0.98±0.15; P<0.01) 231 ( Fig. 2c) and frequency (transients/min; DS1A: 0.41±0.10, DS4A: 0.88±0.16; P<0.01) ( Fig. 2d ) 232
of Ca 2+ transients were significantly different between DS1A and DS4A, whereas the kinetics 233
were similar (T 1/2 , s; DS1A: 8.59±1.01, DS4A: 6.98±0.90; P=0.18) ( Fig. 2e) . These disparities 234 are potentially due to epigenetic changes between the cell lines. 235 
245
Inositol triphosphate (IP 3 )-triggered Ca 2+ release from the endoplasmic reticulum (ER) is 246 considered a primary mechanism responsible for intracellular global Ca 2+ waves 41 . Application 247 of the IP 3 receptor (IP 3 R) antagonist 2-aminoethoxydiphenyl borate (2-APB) abolished 248 spontaneous Ca 2+ fluctuations ( Fig. 2f-i) , as did depletion of intracellular stores by 249 cyclopiazonic acid (CPA), suggesting that IP 3 -ER Ca 2+ underlies both spontaneous and evoked 250 events in DS astroglia. . 3b ), suggesting that Ca 2+ fluctuations do not propagate to adjacent cells. To further 257 examine whether spontaneous fluctuations travel between cells, we performed Ca 2+ imaging in 258 a mixed culture of GCaMP6m-expressing control isogenic astroglia with unlabeled DS4A, in a 259 variety of ratios. Culturing with DS astroglia did not significantly increase the number of Ca 2+ 260 transients in control isogenic astroglia, even with a 10-fold excess of DS4A (Supplementary 261 Fig. 3c ), suggesting that spontaneous Ca 2+ fluctuations were not induced in previously silent 262 control isogenic cells. In addition, application of 10 µM n-octanol, a gap junction blocker, 263 showed no effect on Ca 2+ fluctuations (Supplementary Fig. 3d ). Taken together, these results 264 indicate that the abnormal spontaneous Ca 2+ fluctuations observed in DS astroglia are likely the 265 result of cell-autonomous changes. 266
Previous studies reported that acutely purified human astrocytes acquire sensitivity to 268 extracellular cues such as neurotransmitter ATP and glutamate 42 . To exclude the possibility that 269 differences in functional maturation of differentiated astroglia contributing to suppressed 270 neuronal excitability, we examined transmitter-evoked Ca 2+ responses of DS astroglia and 271 compared with isogenic controls. Both DS and control isogenic astroglia responded robustly to 272 ATP (representative traces shown in Supplementary Fig. 4a-b Fig. 4c-d) . 275
Thus, DS and control astroglia respond similarly to neurotransmitters, further suggesting that 276
Ts21 does not influence functionally maturation of differentiated astrocytes. We next tested whether the suppression of neuronal activity might be caused by the abnormally 281 frequent spontaneous Ca 2+ fluctuations observed in DS astroglia. Since pharmacological block 282 of IP 3 receptors abrogated spontaneous Ca 2+ waves ( Fig.2f-i) , we knocked down (KD) the 283 expression of IP 3 R2, the main IP 3 R isoform in astrocytes, with short hairpin RNAs (shRNAs) in 284 DS astroglia DS4A. IP 3 R2 KD, corresponding to ~50% knockdown (Fig. 3b) (Fig.  287   3a,c) , supporting the pharmacological results. 288
289
We next imaged the activity of neurons co-cultured with DS4A astroglia with knocked-down 290 IP 3 R2. This rescued the reduced amplitude of evoked neuronal Ca 2+ transients (measured as 291 normalized ∆F/F; IP 3 R2 shRNA-1: 0.91±0.0.4, shRNA-2: 0.93±0.03) to the level of isogenic 292 control astroglia (1.01±0.04, P=0.28). In contrast, DS4A with no shRNA (0.60±0.05, P=0.0031) 293 or control-scrambled shRNA (0.62±0.04, P=0.0018) showed significantly decreased neural 294 activity (Fig. 3d) . Therefore, elevated intracellular Ca 2+ fluctuation mediated by IP 3 R2 is 295 necessary to suppress neuronal excitability. As elevated spontaneous astroglia Ca 2+ activity directly contributed to suppressed neuronal 306 activity, we next sought to determine the factors driving elevated Ca 2+ activity in DS astroglia. 307
We first performed single-cell analysis of gene expression related to Ca 2+ signaling pathways 308 (mGluRs, purinergic receptors, GPCRs, and Ca 2+ pumps; Supplementary Fig. 5a ) in DS 309 astroglia. We also monitored the expression of a panel of astrocytic markers to account for the 310 differentiation state of individual cells (Supplementary Fig. 5a-b) . We then performed 311 unsupervised clustering analysis of the cells by their gene expression patterns. We found that (Supplementary Fig. 5d ), distinguished by 313 elevated expression of Ca 2+ handling genes such as ATP2B1, NCX1, RYR1/3, STIM1, NCLX, 314 IP3R3, ORAI1, and chromosome 21 gene S100β (Supplementary Table 1 ). This suggests that 315 a subset of DS astroglia may display elevated spontaneous Ca 2+ fluctuations. In DS astroglia, 316 astrocytic markers such as CD44, CX43, AQP4, NF1A, and ALDOC, were not differentially 317 expressed between the two clusters. 318
319
We next performed a similar analysis of gene expression patterns in control isogenic astroglia 320 (e.g. DS2UA). In contrast, we failed to identify significant clustering ( Supplementary Fig. 5c ) of 321 genes related to the Ca 2+ -handling toolkit. 322 323 Moreover, from the single-cell gene analysis, we found that metabotropic glutamate receptors 324 (GRM1/2/3/4/5/6/7/8) and purinergic receptors were elevated in a subset of DS4UA. We next 325 investigated whether spontaneous fluctuations in DS astroglia could be modulated by 326 pharmacological manipulation of these receptors. ATP treatment led to a 2-fold increase in the 327 frequency and a 1.4-fold increase in the amplitude of spontaneous Ca 2+ fluctuations in ~40% of 328 regions of interest (ROIs) (Fig. 4a) . However, treatment with P2 isotype-specific ATP receptor 329 antagonists (PPADS for P2X, MRS2179 for P2Y; Fig. 4b, Supplementary Fig. 6b ), non-330 specific P2 antagonists (suramin; Fig. 4c ), or an adenosine A 1 -receptor antagonist (DPCPX; Fig.  331 4d) had no significant effect on spontaneous Ca 2+ fluctuations, suggesting that while ATP can 332 modulate spontaneous Ca 2+ events in DS astroglia, it is not sufficient to evoke them. CHPG (a 333 selective mGluR5 agonist) showed no significant effects on amplitude, frequency, or kinetics of 334 spontaneous Ca 2+ fluctuations (Supplementary Fig. 6a) . Similarly, mGluR5-selective (MPEP), 335 non-selective mGluR (MCPG), and mGluR2/3-selective (LY341495) antagonists, as well as a 336 glutamate transporter inhibitor (TFB-TBOA), also had no effect ( Fig. 4e, Supplementary Fig.  337 6c-e). The TRPA1 channel antagonist HC030031 also had no significant effect on spontaneous 338 Ca 2+ fluctuations (Fig. 4f) , consistent with the lack of microdomain Ca 2+ activity observed 43 . In 339 summary, while both intrinsically and extrinsically driven calcium transients depend on IP 3 -340 mediated release from ER stores, our results suggest that spontaneous fluctuations are unlikely 341 to be driven, though can be modified, by extracellular cues. 
S100β regulates spontaneous Ca 2+ fluctuations in DS astroglia 353
From gene analysis, we also noticed that S100β, a Ca 2+ -binding protein located on HSA21 and 354 We first quantified the expression level of S100β in Ts21-derived astroglia. qPCR analysis 362
showed an averaged 11-fold greater expression of S100β in DS astroglia (DS1A and DS4A) 363 compared with control isogenic DS2UA cells (Supplementary Fig. 1c ). Expression of S100β 364 protein was enriched in DS astroglia compared to DS2UA ( Fig. 5a-b; 9 .9-and 10.7-fold 365 increased expression S100β, for DS1A and DS4A, respectively, compared to DS2UA). 366
367
We next selectively knocked down S100β in DS4A, and performed Ca 2+ imaging. We co-368 expressed mCherry as a proxy for the extent of S100β KD and used fluorescence-activated cell 369 sorting (FACS) to select the top 15% of cells with potent S100β KD and use the bottom 15% of 370 cells as a control group with normal S100β levels (Supplementary Fig. 7a) . The S100β KD 371 population contained ~10-fold lower S100β levels compared to the control group (P<0.001) ( Fig.  372   5d) , indicative of effective S100β KD. S100β KD led to a 3.5-fold decrease in spontaneous Ca 2+ 373 transients during a 5-minute window (P<0.001; Fig. 5c, e) . These data suggest that S100β 374 modulates spontaneous Ca 2+ fluctuations in DS astroglia. 
395
Given the reported role of secreted S100β protein in modulating neural activity, we incubated 396 the cultures with antibodies against S100β or Tuj1 (without permeabilization). After 10 minutes 397 incubation, there was no effect on spontaneous Ca 2+ events of either antibody (Supplementary  398   Fig. 7b ), suggesting that the spontaneous Ca 2+ events are mediated by intracellular S100β. 399
400
We then asked whether overexpression of S100β protein would also modulate spontaneous 401 Ca 2+ fluctuations. We overexpressed S100β in DS1A (Fig. 5f) , in which the number of 402 spontaneous Ca 2+ transients is less abundant than DS4A. After two days of expression, we 403 observed a 2-fold increase in the number of Ca 2+ transients (P<0.01; Fig. 5g ). Thus, we 404 conclude that increased cytosolic S100β expression is both necessary and sufficient to drive 405 the spontaneous Ca 2+ fluctuations observed in DS astroglia. 406 407 Finally, we examined whether DS astroglia with spontaneous Ca 2+ fluctuations alleviated by 408 S100β KD still suppressed neuronal excitability. We recorded evoked Ca 2+ events in response to FP stimuli in H9 neurons co-cultured with DS4A with or without S100β KD. H9 neurons co-410 cultured with DS4A with potent S100β KD displayed significantly larger (1.7-fold; P=0.0027) 411 neural activity than those without S100β KD (Fig. 5h) , suggesting that S100β KD successfully 412 rescued neuronal activity suppressed by DS4A. Thus, together with the findings above (Fig. 3d) , 413
we conclude that blocking Ca 2+ fluctuations in DS astroglia by genetic ablation of either IP 3 R2 or 414 S100β is sufficient to rescue the excitability decreases of co-cultured neurons. 415
416
In summary, our data indicate the functional importance of astrocyte-neuron interplay in 417 regulating neuronal excitability in a DS-iPSCs based model. The aberrant Ca 2+ fluctuations in 418 human DS astrocytes depend on intracellular IP 3 -ER Ca 2+ release and are mediated by the 419 overexpression of HSA21 protein S100β. Blocking spontaneous Ca 2+ fluctuations in DS 420 astroglia or adenosine-mediated astrocyte-neuron signaling successfully rescued suppressed 421 neuronal excitability (Fig. 5i) . We further showed functional differences between DS astroglia and control isogenic astroglia in 443 terms of intracellular Ca 2+ dynamics. We observed elevated spontaneous Ca 2+ fluctuations that 444 are frequent and periodic only in DS-derived astroglia, but not in an isogenic control cells. These 445 aberrant Ca 2+ fluctuations in DS astroglia are necessary to drive suppression of global 446 excitability in co-cultured neurons, as evidenced by rescue by genetic or pharmacological block. 447
448
What causes aberrant Ca 2+ fluctuations in DS astroglia? In the present study, we demonstrate 449 that overexpression of cellular S100β in DS astroglia mediates elevated spontaneous Ca 2+ 450 fluctuations, which subsequently regulate neuronal excitability ( Fig. 5g-h) . This finding is of 451 particular interest, as S100β is a Ca 2+ -binding protein. Previous research 47 has shown that 452 secreted S100β stimulates a rise in intracellular Ca 2+ concentration in both neurons and glia. 453
Furthermore, extracellular S100β regulates the firing patterns of neurons by reducing 454 extracellular Ca 2+ concentrations 44 . In our studies, extracellular S100β did not influence 455 spontaneous Ca 2+ fluctuations in DS astroglia, whereas cytosolic of S100β did. Further 456 investigation is necessary to parse the various functions of secreted and cytosolic S100β in 457
healthy and disease-model astrocytes and neurons. 458
459
A major open question in DS research is the mechanism by which the overdose of hundreds of 460 genes on HSA21 disrupts brain function. To date, several candidate genes have been identified, 461
including DYRK1A, SIM2, DSCAM, KCNJ6, NKCC1, and miR-155 1, 48, 49 (Supplementary table  462   1) . Overexpression of S100β, at the distal end of the HSA21 long arm, has been shown to 463 generate reactive oxygen species (ROS) 25 in hiPSC-derived DS astroglia, leading to neuronal 464 apoptosis 3 . Previous research reported that ROS induce lipid peroxidation, activate the PLC-465 IP 3 R pathway, and cause Ca 2+ increases in astrocytes 50 . Indeed, we found that spontaneous 466 Ca 2+ activity was mediated by IP 3 R2-regulated ER stores. Though we do not have direct 467 evidence to link S100β, ROS, and PLC-IP 3 R, S100β might mediate perturbed Ca 2+ dynamics via 468 ROS in DS astroglia. 469
470
Our study provides additional evidence to support the hypothesis that astrocytic Ca 2+ signaling 471 modulates neural activity, critical for brain function during development. A grand challenge is to 472 elucidate the pathways regulating astrocyte-neuron interplay during development. In the present 473 study, our results indicate that astrocyte-neuron interaction via purinergic signaling might be a 474 significant contributor linking aberrant astrocytic Ca 2+ to neuronal functional deficits in DS. We 475 showed that treatment with DPCPX, an adenosine A 1 receptor antagonist, rescued the 476 suppressed Ca 2+ activity of H9 hESC-derived neurons co-cultured with DS astroglia (Fig. 1i) . To 477 what extent ATP potentiates and/or inhibits neuronal activity is still under debate; however, 478 adenosine predominantly inhibits synaptic activity via A 1 receptors [33] [34] [35] . 479
480
In conclusion, the combination of a human iPSC DS model with functional imaging, and 481 pharmacological and genetic manipulation provides a platform for quantitative measurement of 482 human cellular physiology and for mechanistic studies of disease pathophysiology. Though 483 animal models of neurological disorders play an important role in studying the effects of specific 484 genetic and experimental perturbations and in testing potential treatments, they often fail to 485 faithfully recapitulate the full spectrum of human phenotypes, which can lead to false 486 conclusions owing to molecular and cellular differences between the systems. Future 487 improvements to iPSC models will include 3-dimensional culture 51 , multi-color imaging, and 488 incorporating genetically encoded indicators for other molecules and cellular states (e.g. 489 glutamate) 52 . Our imaging platform can be applied to the study of other neurological diseases, 490 as well, even to the level of testing specific drug combinations on neuron-astrocyte co-cultures 491 developed from single healthy or diseased individuals. 492 493 494
Materials and Methods 496
Plasmid construction 497 IP 3 R2, S100β, and scrambled shRNA KD plasmids were ordered from Sigma (MISSION® 498 shRNA Library, pLKO.1 with U6 promoter driving shRNA expression). Lentiviruses were 499 produced in HEK293T cells and used to infect astrocytes. To construct shRNA-mCherry 500 plasmids, shRNA plasmids were digested with KpnI and BamHI (New England BioLabs; Ipswich, 501 MA). mCherry flanked by KpnI and BamHI was ligated into the shRNA vector. To construct PGK 502 promoter-driven S100β, S100β was amplified by PCR using astrocytic cDNA as a template, 503 digested with KpnI and BamHI, and then ligated to plasmids digested with KpnI and BamHI. 504 505
Neural differentiation of human ESCs and iPSCs 506
H9 human ESCs were obtained from WiCell (Madison, WI). Control isogenic trisomy 21 and 507 euploid iPSCs, DS1, DS2U, and DS4, were engineered in Dr. Anita Bhattacharyya's lab, as 508 previously described 4 . H9 ESCs and iPSCs were maintained on matrigel (Becton-Dickinson, 509 356234) in mTeSR1 medium (StemCell Technologies, 05850) . Mycoplasma contamination was 510 tested for routinely. We used previously described protocols for neural differentiation 29 , with 511 minor modifications. Inhibitors of SMAD signaling (10µM SB431542 and 100 nM LDN193189, 512 both from Tocris) were added for the first 6 days to promote neural induction 28 . 513 514
Derivation and culture of astrocytes 515
Control isogenic and DS iPSCs were differentiated into neural progenitors and cultured as 516 spheres for 3 months. The astrospheres were attached to fibronectin-coated dishes (Sigma, 517 F0895), dissociated into single cells, and cultured in an optimized commercial medium for 518 human primary astrocytes (ScienCell Research Laboratories, 1801) . Human primary astrocytes 519 (HA) were also from ScienCell Research Laboratories (1800). We performed karyotype analysis 520 to confirm the trisomy states of DS1-and DS4-derived astroglia (DS1A and DS4A), and the 521 disomy state of control isogenic line DS2U-derived astroglia (DS2UA), prior to and after the Ca 2+ 522 experiments using a service provided by Cell Line Genetics. Indeed, chromosome alteration 523 usually occurs more frequently during the maintenance of iPSCs before differentiation 53 . 524
The cell size was analyzed by randomly selecting 5 cells from 3 bright field images. Pixel areas 525 of each selected cell were calculated and averaged in ImageJ. 526 527
Lentivirus production 528
Lentiviruses were produced by co-transfecting HEK293T cells (ATCC) with 5 µg pSIV-Synapsin-529 1-GCaMP6m or pHIV-EF1α-Lck-GCaMP6m, scrambled or S100β shRNAs, 2 µg pHCMV-G, and 530 3 µg pCMV-deltaR8.2, using 40 µl SuperFect (Qiagen, 301305). Supernatant containing viral 531 particles was collected, filtered, and concentrated 72 h later with an Ultra-4 centrifugal filter 532 (Millipore, UFC810024). 533 534
Ca 2+ imaging and analysis in astrocytes 535
Primary astrocytes or iPSC-derived astrocytes were seeded onto 8-well slides (Ibidi, 80826, 536 optically clear), coated with fibronectin and infected with lentiviruses encoding GCaMP6m driven 537 by the EF1α promoter, then subjected to Ca 2+ imaging. For IP 3 R2 KD, DS4A cells were infected 538 with lentiviruses encoding shRNA and GCaMP6m; Ca 2+ imaging followed. For S100β KD, DS4A 539 cells were infected with lentiviruses encoding shRNA, sorted into 2 populations by FACS 540 according to mCherry intensity, and infected with GCaMP6m for each population; Ca 2+ imaging 541 followed. For each cell line, 3 Ca 2+ -imaging sessions (each session contains 3 fields of view) 542
were collected from independent samples. For mixed cultures of control isogenic and DS 543 astrocytes, control isogenic DS2UA were first infected with lentiviruses expressing EF1α-544
GCaMP6m, then seeded with DS4A, followed by Ca 2+ imaging. Three days post-infection, frame 545 scans were acquired at 2 Hz (512x512 pixels) for a period of 300 s using a Zeiss LSM 710 546 confocal microscope (× 20 magnification, N.A.=0.8 objective). Agonists or antagonists (Tocris) 547 were added at frame 10 during continuous imaging. For quantification of ATP and glutamate-548 evoked activity, to eliminate the confound of spontaneous activity, only ROIs that were silent 549 during the initial imaging period were analyzed for a response to added ATP or glutamate. 550
Furthermore, we ensured that these evoked responses were time-locked to agonist application. 551
552
Because of these complex spatiotemporal patterns of Ca 2+ dynamics in astrocytes, we 553 developed a computational tool, named FASP 40 , to quantitatively and automatically analyze the 554 large-scale imaging datasets to ensure that the analysis is identical and objective for all cells 555
and across experiments. As an unsupervised analytic method, FASP is data-driven, learning 556 model parameters using machine-learning techniques to automatically detect ROIs displaying 557 Ca 2+ fluctuation. In addition, designed under probabilistic principles, FASP has strong statistical 558 power to detect weak signals (ROIs) that are easily ignored by purely manual analysis. Our 559 simulation study verified that some ROIs with weak signals were ignored by manual analysis but 560 correctly detected by FASP. By judicious application of various statistical theories, FASP 561 confers tuning parameters with probabilistic meaning, which can be directly translated into the 562 false discovery rates. This algorithm greatly facilitates the usability of parameter settings and 563 ensures the reproducibility of the results and equal comparison across experiments. 564 565 Specifically, we set a single threshold corresponding to a false discovery rate of 0.01; that is, an 566 average of 1% of all identified active ROIs are expected to be false positives. The threshold is 567 fixed for all experiments and conditions. 568 569 Given a time-lapse astrocytic Ca 2+ -imaging data set, FASP generates a set of ROIs and 570 corresponding characteristic curves. For each pixel in an ROI, there is a corresponding activity 571 curve for which the time shift with respect to the characteristic curve is also estimated. Based on 572 the results of FASP, we quantified various parameters of astrocytic Ca 2+ signals according to the 573 following: 574
• The signal-to-baseline ratio of fluorescence was calculated as 575
where the baseline fluorescence ! is estimated as the 10 th percentile of the 577 fluorescence level over all time points of the measurement. 578
• The number of Ca 2+ transients is calculated as the number of peak responses from all 579
ROIs detected in each time-lapse imaging session. 580
• The number of active ROIs is calculated as the total number of ROIs detected by FASP 581 in the field of view of each time-lapse imaging session. 582 583 Amplitude: To calculate the amplitude of a Ca 2+ transient we first transformed the raw time-584 intensity curves into signal-to-baseline ratio of fluorescence (ΔF/F0=(F-F0)/F0), where the 585 baseline fluorescence F0 is estimated as the 10 th percentile of the fluorescence levels 586
(intensities) at all the time points during measurement. 587 588 Frequency: To calculate the frequency of Ca 2+ fluctuations more reliably, we first determined 589 the average duration between 2 contiguous events, and then defined the frequency as the 590 inverse of the average duration. For those ROIs that only displayed single Ca 2+ transients during 591 the imaging session, the information contained in the single-event time series is insufficient for 592 point estimation of frequency. These ROIs are expected to have a positive frequency between 0 593 and 0.2 transients per minute. 594
